Login
Subscribe
Opinion: New Diabetes Drug Signals Shift to Preventing Autoimmunity
Opinion: New Diabetes Drug Signals Shift to Preventing Autoimmunity
A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.
A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.
diabetes, immunology
Relevant Models Reflect Real-World Needs
The Scientist | May 30, 2023 | 1 min read
Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.
Connecting the Dots That Link Diabetes and Infection Severity
Deanna MacNeil, PhD | May 22, 2023 | 4 min read
Researchers shed light on the immunometabolism of respiratory infection, providing an avenue towards safer COVID-19 therapeutics for those affected by metabolic disorders.
An Implantable Device for Type 1 Diabetes Treatment
Elina Kadriu | Apr 18, 2023 | 3 min read
Engineering of a novel device to treat T1D, featuring local immunosuppression and a vascularized cell reservoir to prolong islet cell survival.
How a Specific Gut Bacterium May Cause Type 1 Diabetes
Dan Robitzski | Aug 25, 2022 | 5 min read
A bacterium that produces an insulin-like peptide can give mice type 1 diabetes, and infection with the microbe seems to predict the onset of the disease in humans, a study finds.
Diabetes Marker Linked to COVID-19 Severity in Mice
Alejandra Manjarrez, PhD | May 16, 2022 | 3 min read
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016 | 10 min read
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.